Source: Pharmabiz

FUJIFILM: Fujifilm Diosynth Biotechnologies& Regeneron ink a 10year US manufacturing supply agreement valued at over $3 billion

Fujifilm Diosynth Biotechnologies, a world─leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, announced a 10─year manufacturing supply

Read full article »
Annual Revenue
$10-50B
Employees
50-100K
Teiichi Goto's photo - President & CEO of FUJIFILM

President & CEO

Teiichi Goto

CEO Approval Rating

57/100

Read more